Cleared Traditional

K942685 - ECG REVIEW STATION

K942685 is the FDA 510(k) clearance for ECG REVIEW STATION by Mortara Instrument, Inc.. It is a Class 2 Cardiovascular device (product code DXJ) cleared through the Traditional 510(k) pathway after a 1162-day FDA review.

K942685 · Mortara Instrument, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1997
Decision
1162d
Days
Class 2
Risk

K942685 is an FDA 510(k) clearance for the ECG REVIEW STATION. Classified as Display, Cathode-ray Tube, Medical (product code DXJ), Class II - Special Controls.

Submitted by Mortara Instrument, Inc. (Milwaukee, US). The FDA issued a Cleared decision on August 12, 1997 after a review of 1162 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Mortara Instrument, Inc. devices

Submission Details

510(k) Number K942685 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 1994
Decision Date August 12, 1997
Days to Decision 1162 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1037d slower than avg
Panel avg: 125d · This submission: 1162d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXJ Display, Cathode-ray Tube, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXJ Display, Cathode-ray Tube, Medical

All 40
Devices cleared under the same product code (DXJ) and FDA review panel - the closest regulatory comparables to K942685.
MODIFICATION TO: CIC PRO CLINICAL INFORMATION CENTER CENTRAL STATION
K053356 · Ge Medical Systems Information Technologies · Apr 2006
INFINITY EXPLORER
K013515 · Siemens Medical Solutions USA, Inc. · Jan 2002
HP CAREVUE 9000 CLINICAL INFORMATION SYSTEM, MODEL M2331A
K992636 · Hewlett-Packard Co. · Aug 1999
HEWLETT-PACKARD MODEL M1490A WIRELESS PATIENT DATA COMMUNICATOR
K945277 · Hewlett-Packard Co. · Jan 1995
MODEL M1251A MON. FULL DISCLOSURE REVIEW SYSTEM
K905788 · Hewlett-Packard Co. · Jun 1991
CENTRALSCOPE 12
K901072 · Marquette Electronics, Inc. · Aug 1990